Tissue Repair Ltd (ASX:TRP)

Tissue Repair Statistics

Total Valuation

Tissue Repair has a market cap or net worth of AUD 12.40 million. The enterprise value is 76,812.

Market Cap	12.40M
Enterprise Value	76,812

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Tissue Repair has 60.46 million shares outstanding.

Current Share Class	60.46M
Shares Outstanding	60.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	12.44%
Owned by Institutions (%)	10.29%
Float	34.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.71
PB Ratio	0.89
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.02
EV / Sales	0.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.02

Financial Position

The company has a current ratio of 22.40

Current Ratio	22.40
Quick Ratio	22.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.53% and return on invested capital (ROIC) is -18.88%.

Return on Equity (ROE)	-26.53%
Return on Assets (ROA)	-17.76%
Return on Invested Capital (ROIC)	-18.88%
Return on Capital Employed (ROCE)	-34.62%
Weighted Average Cost of Capital (WACC)	6.78%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.07% in the last 52 weeks. The beta is 0.46, so Tissue Repair's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-28.07%
50-Day Moving Average	0.34
200-Day Moving Average	0.28
Relative Strength Index (RSI)	21.20
Average Volume (20 Days)	127,544

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Tissue Repair had revenue of AUD 2.63 million and -4.24 million in losses. Loss per share was -0.07.

Revenue	2.63M
Gross Profit	2.63M
Operating Income	-4.83M
Pretax Income	-4.24M
Net Income	-4.24M
EBITDA	-4.72M
EBIT	-4.83M
Loss Per Share	-0.07

Balance Sheet

The company has 12.32 million in cash and n/a in debt, with a net cash position of 12.32 million or 0.20 per share.

Cash & Cash Equivalents	12.32M
Total Debt	n/a
Net Cash	12.32M
Net Cash Per Share	0.20
Equity (Book Value)	13.91M
Book Value Per Share	0.23
Working Capital	13.62M

Cash Flow

In the last 12 months, operating cash flow was -3.70 million and capital expenditures -421,669, giving a free cash flow of -4.12 million.

Operating Cash Flow	-3.70M
Capital Expenditures	-421,669
Free Cash Flow	-4.12M
FCF Per Share	-0.07

Margins

Gross margin is 100.00%, with operating and profit margins of -183.24% and -160.96%.

Gross Margin	100.00%
Operating Margin	-183.24%
Pretax Margin	-160.96%
Profit Margin	-160.96%
EBITDA Margin	-179.30%
EBIT Margin	-183.24%
FCF Margin	n/a

Dividends & Yields

Tissue Repair does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-34.19%
FCF Yield	-33.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Tissue Repair has an Altman Z-Score of 13.95 and a Piotroski F-Score of 3.

Altman Z-Score	13.95
Piotroski F-Score	3